Protara Therapeutics, Inc. Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount
Protara Therapeutics, Inc. (TARA) reported Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount of $40.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherReconcilingItems · last filed 2026-03-10
- Protara Therapeutics, Inc. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2025 was $40.00K, a 71.83% decline from fiscal 2024.
- Protara Therapeutics, Inc. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2024 was $142.00K.
- Protara Therapeutics, Inc. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2014 was $312.00K, a 87.84% decline from fiscal 2013.
- Protara Therapeutics, Inc. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2013 was $2.57M, a 794.08% increase from fiscal 2012.
| Period end | Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount 12 month |
|---|---|
| 2025-12-31 | $40.00K 10-K · filed 2026-03-10 |
| 2024-12-31 | $142.00K 10-K · filed 2026-03-10 |
| 2014-12-31 | $312.00K 10-K · filed 2017-03-16 |
| 2013-12-31 | $2.57M 10-K · filed 2016-03-14 |
| 2012-12-31 | $287.00K 10-K · filed 2015-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |